Zofran (ondansetron) is generally well tolerated, and most people who take it for nausea experience only mild side effects such as headache, constipation, and fatigue. The drug works by blocking a specific serotonin receptor involved in triggering nausea and vomiting, and that narrow mechanism is a big part of why it causes fewer problems than older anti-nausea medications. But “well tolerated” does not mean risk-free. Certain people face serious cardiac, allergic, or reproductive concerns that deserve a closer look, and the risk picture shifts meaningfully depending on age, other medications, pregnancy status, and even individual genetics.
The Common, Everyday Side Effects
For the majority of people prescribed Zofran, the side-effect profile is mild. Headache is the most frequently reported complaint, followed by constipation, dizziness, and a general sense of tiredness. Some people notice brief warmth or flushing at the injection site when the drug is given intravenously. These reactions tend to be short-lived and rarely lead someone to stop taking the medication. Early pharmacological reviews emphasized that ondansetron’s high selectivity for a single receptor type keeps its side-effect list short compared with drugs that interact with multiple brain pathways.1PubMed. Pharmacology of ondansetron
Constipation is worth calling out specifically because it catches people off guard. Serotonin plays a major role in gut motility, and blocking its receptors can slow the movement of food through the intestines. For most people this means a day or two of sluggish bowels. In rare cases, especially with prolonged use, the slowdown can be more significant. At least one report documented intestinal obstruction in a pregnant woman taking ondansetron for severe nausea, and a review of spontaneous reports to the World Health Organization suggested the complication may be more common than the published medical literature indicates.2PubMed Central. Comparison of the Effects of Metoclopramide and Ondansetron on Emergency Service Observation Times in Acute Gastroenteritis-Related Nausea and Vomiting Cases If you are already prone to constipation or are taking opioids that further slow the gut, it is worth mentioning this to your doctor before starting Zofran.
The Heart Rhythm Risk
The side effect that gets the most serious attention from regulators is QT prolongation, a change in the heart’s electrical cycle that can, in rare cases, lead to a dangerous irregular rhythm called torsades de pointes. In 2011 the FDA issued a warning about dose-related QT prolongation with ondansetron, and subsequent guidelines lowered the maximum recommended intravenous dose. The concern is real but heavily concentrated in people who already have risk factors.
A large independent analysis of adverse-event reports found that the vast majority of arrhythmia cases linked to ondansetron involved intravenous administration, not oral tablets. Roughly four in five reports were IV cases, and most patients had a significant medical history or were simultaneously taking another drug known to prolong the QT interval.3PubMed Central. Ondansetron induced torsades de pointes No reports of an arrhythmia linked to a single oral dose were identified in that analysis. That does not mean oral Zofran is zero-risk for the heart, but it suggests the risk is orders of magnitude lower than with IV dosing, especially at higher infusion speeds.
Case reports illustrate how things can go wrong in high-risk settings. One emergency-department case described a patient who received just 4 mg of IV ondansetron and within a minute showed a markedly prolonged QT interval, then suffered torsades de pointes and cardiac arrest roughly thirteen minutes later.4PubMed. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron Another case involved a 43-year-old woman with no prior heart history who experienced ventricular fibrillation and cardiac arrest after ondansetron administration. Critically, she had low magnesium, low calcium, and borderline-low potassium, all of which can destabilize the heart’s electrical system.5PubMed Central. Ondansetron-induced cardiac arrest and cardiomyopathy with successful reversal: a case report These cases are rare, but they reinforce the point that electrolyte status matters enormously when ondansetron is in play.
Who Faces the Highest Cardiac Risk
Not everyone taking Zofran needs to worry about their heart rhythm. The people most at risk share a recognizable pattern of characteristics. The FDA and medical reviews consistently highlight the same set of predisposing factors: underlying heart conditions (especially congenital long-QT syndrome), low potassium, low magnesium, or low calcium in the blood, and concurrent use of other medications that also lengthen the QT interval.6PubMed. Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article That last category is broader than you might think. Common drugs in that group include certain antibiotics, antidepressants, antipsychotics, and even some other anti-nausea medications.
Age is another factor. A systematic review and meta-analysis looking at QT prolongation across age groups found a statistically significant prevalence of about 23% in participants older than 50, compared with lower rates in younger adults.7PubMed Central. Ondansetron-induced QT prolongation among various age groups: a systematic review and meta-analysis The researchers attributed this to age-related changes in the heart’s electrical conduction system, the higher likelihood of being on multiple medications simultaneously, the greater prevalence of conditions like heart disease and electrolyte imbalances, and reduced liver and kidney function that can slow drug clearance. If you are an older adult taking several prescriptions, your physician should be checking your electrolytes and reviewing your medication list before adding Zofran.
Allergic and Hypersensitivity Reactions
True allergic reactions to ondansetron are uncommon but documented. They range from mild skin reactions like itching and rashes to life-threatening anaphylactic shock. One case report described a six-year-old girl who developed itching and rashes after a single intravenous dose.8PubMed Central. Hypersensitivity reaction to intravenous ondansetron: A case report More severe reactions, including hypotension, seizures, and anaphylaxis, have also been reported with serotonin-receptor antagonists in the same drug class.9PubMed Central. Hypersensitivity to intravenous ondansetron: a case report
A deeper analysis of anaphylactic-shock cases linked to ondansetron confirmed that while these events are rare, they do occur and can be fatal if not treated immediately.10PubMed Central. Ondansetron-Induced Anaphylactic Shock: An In-Depth Analysis of a Rare Adverse Event The practical takeaway here is simple: if you have ever had a reaction to Zofran or another anti-nausea drug in the same class (granisetron, dolasetron, palonosetron), make sure every provider you see knows about it. Cross-reactivity within this drug family is possible.
Zofran During Pregnancy
Ondansetron is one of the most commonly prescribed medications for severe nausea and vomiting during pregnancy, even though it is technically an off-label use. That widespread prescribing has generated a large body of safety research, and the results are somewhat mixed when it comes to the baby’s heart.
The largest and most reassuring study comes from a national cohort of publicly insured pregnant women in the United States. After adjusting for a wide range of confounding factors, researchers found no association between first-trimester ondansetron exposure and cardiac malformations or congenital malformations overall. The adjusted relative risk for cardiac malformations was essentially 1.0, with a narrow confidence interval that makes the finding fairly precise.11JAMA. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring
On the other hand, a study that specifically zoomed in on ventricular septal defects, the most common type of congenital heart defect, found a small but statistically meaningful increase in risk. The analysis estimated roughly one additional case for every 330 pregnancies exposed in the first trimester, and the association appeared to be dose-dependent: women who received the highest cumulative doses had about three times the risk compared with those receiving the lowest doses.12PubMed Central. Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect
How do you reconcile these findings? The broad-spectrum study found no increase in cardiac malformations as a whole, while the more focused study found a signal for one specific subtype when looking at higher doses. Most obstetric guidelines treat ondansetron as a reasonable option for pregnancy nausea when other approaches have failed, but they advise using the lowest effective dose for the shortest necessary time. If you are pregnant and debating whether to take Zofran, the honest summary is that the absolute risk increase, even in the study that found one, is small. But it is not zero, and the dose-response pattern suggests that restraint with dosing is prudent.
Serotonin Syndrome Concerns
Zofran’s FDA label carries a warning about serotonin syndrome, a potentially dangerous condition caused by excessive serotonin activity. Because ondansetron blocks one type of serotonin receptor, many clinicians worry about combining it with other serotonin-active drugs like SSRIs, SNRIs, or tramadol. In practice, the pharmacological case for this concern is weak. Ondansetron blocks the 5-HT3 receptor, while serotonin syndrome is primarily driven by overstimulation of a different receptor, 5-HT1A. A detailed pharmacological review concluded that attributing serotonin toxicity to ondansetron at standard doses is often mechanistically unfounded, and that despite the extremely common practice of co-prescribing ondansetron with antidepressants, actual cases of serotonin syndrome remain exceedingly rare.13PubMed Central. Can 5-HT3 Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order
This does not mean you should ignore the warning entirely. In overdose situations or when combined with drugs that dramatically increase serotonin levels, any serotonergic medication theoretically adds risk. But if your doctor prescribes Zofran alongside your SSRI, the combination is generally considered safe at recommended doses, and a blanket refusal to use ondansetron because of the serotonin syndrome label would leave many patients without an effective anti-nausea option.
A Rare Visual Side Effect
One of the more surprising entries in ondansetron’s adverse-event profile is transient blindness. A pharmacovigilance study that screened a global database of adverse drug reactions found 44 blindness-related reports linked to ondansetron, representing about a third of all blindness reports associated with anti-emetic drugs. The reporting odds ratio was four times higher for ondansetron than for other anti-emetics in the database. Most episodes occurred on the first day of use, and among the 25 patients whose outcomes were known, about three-quarters recovered their vision.14PubMed Central. CYP2D6 genotype and associated 5-HT(3) receptor antagonist outcomes: A systematic review and meta-analysis The mechanism is not fully understood, and the absolute number of cases is tiny relative to the millions of doses given worldwide. Still, if you experience sudden visual changes after taking Zofran, this is something your medical team should know about immediately.
Liver Disease and Dose Limits
Ondansetron is broken down almost entirely by the liver, so any impairment in liver function changes the equation. In patients with severe liver disease, the drug’s clearance drops significantly, meaning it stays in the body longer and at higher concentrations. Pharmacokinetic research established that patients with severe hepatic insufficiency should have their total daily dose limited to no more than 8 mg.15PubMed. Pharmacokinetics of ondansetron in patients with hepatic insufficiency Because higher blood levels of ondansetron amplify every side effect, including the QT-prolongation risk, this dose ceiling is an important safeguard. If you have cirrhosis, hepatitis, or another liver condition, make sure whoever prescribes your Zofran is aware, because the standard dosing assumptions do not apply to you.
Genetics and Why the Drug Works Differently in Different People
One reason two people can take the same Zofran dose and have very different experiences is genetic variation in the liver enzyme CYP2D6, which is a primary pathway for metabolizing ondansetron. People carry different versions of the gene that codes for this enzyme, and those versions can result in metabolism that ranges from ultrarapid to essentially absent. A systematic review and meta-analysis confirmed that CYP2D6 genotype affects ondansetron’s effectiveness in preventing postoperative nausea and vomiting.16PubMed Central. CYP2D6 genotype and associated 5-HT(3) receptor antagonist outcomes: A systematic review and meta-analysis
Updated clinical guidelines now recommend considering CYP2D6 genotype when selecting and dosing serotonin-receptor antagonist anti-emetics.17PubMed Central. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 Genotype and Use of 5-HT(3) Receptor Antagonists: 2026 Update Ultrarapid metabolizers clear the drug so quickly that it may not work well at standard doses. Poor metabolizers break it down much more slowly, leading to higher blood levels and potentially more side effects, including a greater risk of QT prolongation. Pharmacogenomic testing is not yet routine before every Zofran prescription, but it is increasingly available, and if the drug seems to either fail you completely or hit you unusually hard, CYP2D6 status is a plausible explanation worth investigating.
How Zofran Compares to Other Anti-Nausea Drugs
In head-to-head comparisons, ondansetron typically comes out looking cleaner than the older alternatives, which is a big part of why it became so popular. Metoclopramide, the most commonly compared drug, works through a different mechanism and carries well-known side effects related to involuntary movement. In one randomized controlled trial of pregnant women with severe nausea, the metoclopramide group had significantly higher rates of drowsiness (about 30% versus 12.5%) and dry mouth (about 24% versus 10%) compared with the ondansetron group.18PubMed Central. Ondansetron versus metoclopramide for managing hyperemesis gravidarum: A systematic review and meta-analysis of randomized controlled trials In another trial focused on acute gastroenteritis in an emergency department, patients on metoclopramide experienced drowsiness and restlessness, while patients on ondansetron reported no side effects at all.19PubMed Central. Comparison of the Effects of Metoclopramide and Ondansetron on Emergency Service Observation Times in Acute Gastroenteritis-Related Nausea and Vomiting Cases
The trade-off is that ondansetron’s cardiac risk, while rare, is a category of concern that metoclopramide does not share in the same way. Metoclopramide’s risks tend to be neurological: movement disorders, drowsiness, and in rare prolonged-use cases, a condition called tardive dyskinesia. So the choice between anti-nausea medications is not a matter of one being universally safer; it is about which risk profile is more acceptable given a particular patient’s health history.
Zofran in Children
Ondansetron is widely used in pediatric emergency departments to treat vomiting from stomach bugs, and the evidence generally supports its safety in children. A meta-analysis of trials in children with acute gastroenteritis found that adverse effects were similar between ondansetron and placebo groups.20PubMed. Systematic review with meta-analysis: ondansetron for vomiting in children with acute gastroenteritis A landmark trial in a pediatric emergency department found that oral ondansetron reduced vomiting and shortened the time children spent in the ED by about 12%, though it did not reduce the rate of hospital admission.21PubMed. Oral ondansetron for gastroenteritis in a pediatric emergency department
Some evidence suggests ondansetron is better tolerated and has a better side-effect profile than other anti-emetics used in children, though the decision to use it remains at the treating physician’s discretion, and potential adverse events should still be weighed against the benefits.22PubMed Central. Ondansetron for acute gastroenteritis in children For parents, the practical message is that Zofran given to a vomiting child in the emergency department is one of the more evidence-supported uses of the drug, and serious side effects in the pediatric population are uncommon. The same cardiac considerations that apply to adults still apply in theory, particularly in children with congenital heart conditions or electrolyte problems from severe dehydration, but the real-world frequency of such events in otherwise healthy children is very low.
The Oral-Versus-IV Distinction
One pattern that runs through nearly all the serious adverse-event reports is worth making explicit: the route of administration matters. The cardiac arrest cases, the QT-prolongation concerns that triggered the FDA warning, and the bulk of the arrhythmia reports in pharmacovigilance databases overwhelmingly involve intravenous ondansetron.23PubMed Central. Ondansetron induced torsades de pointes IV administration delivers the drug rapidly into the bloodstream, producing a higher peak concentration than oral dosing. That sharp spike is what stresses the heart’s electrical system.
If you are taking Zofran as an oral dissolving tablet or swallowed pill at home for nausea, your risk of a serious cardiac event is dramatically lower than what the scariest case reports might suggest. Those reports almost always describe hospitalized patients receiving IV doses, frequently alongside chemotherapy drugs or in the setting of recent surgery, electrolyte derangements, or pre-existing cardiac disease. That does not make oral Zofran risk-free, but it is worth keeping the context in mind if a headline or drug-label warning has you anxious about a medication your doctor prescribed for a stomach virus.